For over 30 years, the Quattro range has been a trusted name in high-quality, clinically effective pressure ulcer prevention.
Now, with Quattro Plus Nexus, we are making this proven 1-in-4 technology more accessible than ever. Retaining the same UK-manufactured control unit that healthcare professionals rely on, Quattro Plus Nexus delivers advanced pressure ulcer prevention and management with a streamlined, cost-effective feature set.
Designed to maintain the high standards of the Quattro range, the Quattro Plus Nexus ensures more patients can benefit from 1-in-4 alternation technology, therapy choice, and reliability – without compromise.
By expanding access to high-quality support surfaces, Quattro Plus Nexus supports both clinical and budgetary needs, helping to enhance patient outcomes in a wider range of care settings.
Suitable for all patient types, the Quattro® Plus Nexus mattress system provides an active 1-in-4 cell cycle or Continuous Low Pressure (CLP), to provide patients with pressure relief, or pressure redistribution, to prevent and manage patients at risk of or with existing pressure ulcers.
The active 1-in-4 cell cycle supports 75% of the patient’s body at all times, on groups of three inflated cells, whilst the fourth cell deflates sufficiently to redistribute the pressure and encourage tissue reperfusion. Additional benefits of the 1-in-4 system may include increased patient comfort, and less awareness of the support surface movement.
